August 18
Building the First New Therapeutic Approach to Periodontitis in Decades
Read more
Brandon BioCatalyst is the largest life science investment fund in Australia and New Zealand. We are a unique collaboration between major Australian superannuation funds, CSL, the Australian and New Zealand governments, Australian state governments and more than 50 leading medical research institutes and research hospitals.
Learn more about who we areA clinical stage company developing treatment for hot flashes in cancer survivors undergoing endocrine therapy
View ProjectDeveloping disease-modifying mitochondrial therapeutics for neurodegenerative disorders
View ProjectDeveloping the next generation of CAR-T cell therapies to treat solid cancers
View ProjectCombining non-opioid analgesics and biopolymers to deliver weeks of localised pain management
View ProjectUnlocking the potential of N-myristoyltransferase (NMT) to develop precision medicines for a range of diseases including cancer and viral infections
View ProjectGlyscend is developing novel non-absorbable polymers that are orally-delivered for the treatment of Type 2 Diabetes.
View ProjectSVI is an independent medical research institute that conducts research into the cause, prevention and treatment of diseases that are common and have serious effects on health. We strive, through our research, to help alleviate the enormous financial, emotional and physical impacts of these diseases on individuals, their families and the community.
ViewCallaghan Innovation is the New Zealand government’s innovation agency, helping businesses succeed through technology. We act as a gateway to innovation in New Zealand by connecting the rest of the world to Kiwi companies, research institutes, incubators, universities and commercialisation offices.
ViewThe Florey Institute of Neuroscience and Mental Health is one of the largest and highly respected brain research centres in the world.
ViewBrandon BioCatalyst is innovation in action: We provide a path for taking medical science from conception into the real world.
Our Venture capital model is unique. We don’t simply provide investment, we partner with entrepreneurs to create businesses, run companies and everything necessary to ensure our investments succeed.
Learn moreSix Australian startup health innovators awarded $13.5 million through CUREator+ to accelerate breakthrough medical therapies and technologies.
Read moreKraken Coding: from hospital pharmacy to health-tech founder on a mission to help clinicians make faster, safer decisions
Read more